Maxcoolsan
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Korea Pavis Pharmaceutical Co., Ltd.
MFDS item code 201400865 · Notified 2014.02.25 · Insurance code 621802470
Improved preparation for examination through bowel cleansing before colon examination
This is a bowel cleansing agent used to completely empty the bowel before colon (X-ray, endoscopy) examinations. This medication helps to remove waste and residues from the bowel prior to the examination in order to obtain accurate results. It is primarily used to clean the bowel completely before colonoscopy or colon X-ray examination.
Adults 18 years of age and older: Take the doses below, either as a split dose or as a single dose. (Drug A (sachet), Drug B (sachet)) [Preparation of the solution] Place 1 sachet of Drug A and 1 sachet of Drug B in a disposable container (500mL), dissolve in an appropriate amount of water, then add water to the 500mL mark and shake well to prepare a homogeneous solution. Prepare the solution 4 times, 500mL each time. If needed, the solution may be refrigerated before drinking. Store the prepared solution refrigerated and use within 24 hours. [Directions for administration] 1) Split-dose regimen: On the evening before colonoscopy, drink 1L of the prepared solution (500mL solution × 2 preparations) over 1 hour (one 250mL cup every 15 minutes), then drink an additional 500ml of water. The next morning, drink 1L of the prepared solution (500mL solution × 2 preparations) over 1 hour, then drink an additional 500ml of water. This process must be completed at least 1 hour before the colonoscopy begins. 2) Non-split evening regimen: At around 6 p.m. on the evening before colonoscopy, drink 1L of the prepared solution (500mL solution × 2 preparations) over 1 hour (one 250mL cup every 15 minutes), then, after 1.5 hours, drink 1L of the prepared solution (500mL solution × 2 preparations) over 1 hour, followed by an additional 1L of water.
This medication can rarely cause generalized tonic-clonic seizures in patients without a history of seizures, so particular caution should be taken for patients with electrolyte abnormalities or those taking medications that pose a high risk for electrolyte abnormalities. This medication should not be used in cases of bowel obstruction, gastrointestinal obstruction, perforation, toxic colitis, or toxic megacolon, and should be used with caution in patients with severe ulcerative colitis. Patients with hypersensitivity to this drug or its components, suspected gastrointestinal obstruction or perforation, dehydration or severe heart failure, patients with active cancer, gastroparesis, glucose-6-phosphate dehydrogenase deficiency, patients with coma, and children under 18 years of age should not be administered this drug. Caution is advised for patients with bowel strictures, severe constipation, elderly patients, frail patients, those with impaired vomiting reflex or altered consciousness, patients at high risk for pulmonary aspiration, patients with severe renal impairment, those with acute severe inflammatory diseases, patients with dysphagia, those with severe abdominal distension or pain, and patients with severe ulcerative colitis. Various adverse reactions have been reported with this medication, including hunger, electrolyte abnormalities, sleep disturbances, dizziness, headache, abdominal pain, nausea, abdominal distension, vomiting, dyspepsia, lethargy, thirst, tremors, liver dysfunction, etc. Particularly in the elderly, caution is necessary as bleeding due to gastric mucosal damage, esophageal perforation, cardiac arrest, and acute pulmonary edema may occur. Prior to administration, the bowel status of the patient should be verified, and during administration, bowel movements should be observed for appropriateness. Bowel activity usually begins about one hour after administration, and if abdominal distension or pain occurs, the rate of administration should be adjusted or discontinued, and examination should be sought if necessary. If symptoms of fluid or electrolyte abnormalities appear, blood tests should be performed to check the status and appropriate treatment should be instituted. For patients at risk of cardiac disease or electrolyte imbalance, electrocardiograms and renal function tests should be conducted, particularly in those at high risk for arrhythmias. This medication can cause diarrhea, so adequate fluid intake is necessary. The risk of mucosal ulceration or ischemic colitis increases when used with irritant laxatives, so it is advisable not to use them together. Before administration, care must be taken as the absorption of medications taken within one hour prior may be inhibited, particularly for those with a narrow therapeutic range or short half-life. Pregnant or nursing women should only use this medication when the diagnostic benefits outweigh the risks, and safety and efficacy in pediatric patients have not been established, so it should not be administered to them. The elderly may be more sensitive to this medication, increasing the risk of side effects, so use with caution. Overdose may cause dehydration, decreased blood volume, and electrolyte abnormalities, so careful monitoring and treatment are required in cases of overdose. This medication should be compounded without adding other components or fragrances, and should be dissolved in water and taken immediately; any solution not used within 24 hours should be discarded. Store this medication in a tightly sealed container to prevent exposure to air or moisture. Additionally, it should be stored at a safe temperature between 1 to 30 degrees Celsius.
hunger, hypophosphatemia, hypokalemia, sleep disturbances, dizziness, headache, upper abdominal pain, abdominal pain, nausea, abdominal bloating, anal discomfort, vomiting, indigestion, dysphagia, fatigue, thirst, tremors, discomfort, decrease in serum bicarbonate, decrease in serum calcium, hypercalcemia, decrease or increase in serum chloride, increase in serum phosphate, liver dysfunction, rash, urticaria, runny nose, dermatitis, edema, anaphylactoid reaction, upper gastrointestinal bleeding due to gastric mucosal damage, esophageal perforation, cardiac arrest, acute pulmonary edema, tachycardia, palpitations, hypertension, arrhythmia, atrial fibrillation, peripheral edema, syncope, dehydration, anaphylactic reaction, itching, lip swelling, tongue swelling, facial swelling, dyspnea, chest tightness, throat tightness, fever, chills, tremors, seizures, renal dysfunction, renal failure
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It should also be safely stored at a temperature between 1 to 30 degrees Celsius.
Preparation A: A white or off-white powder with a lemon scent packed in aluminum foil pouch. Preparation B: A white to off-white crystalline or crystalline powder with no odor and a sour taste packed in aluminum foil pouch.
1 box (Preparation A 4 packets + Preparation B 4 packets)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Korea Pavis Pharmaceutical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Taejun Pharmaceutical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Hanook Pharma Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Albozen Korea Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
Huons Co., Ltd.
Sodium Chloride 1.3455g · Potassium Chloride 0.5075g +4 more
Prescription medication · Combination
Highple Biomedical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Polyethylene Glycol 3350 50g · Anhydrous Sodium Sulfate 3.75g +4 more
Prescription medication · Combination
IntroBioPharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.